These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32110058)

  • 1. FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.
    Chen Y; Deng G; Fu Y; Han Y; Guo C; Yin L; Cai C; Shen H; Wu S; Zeng S
    Onco Targets Ther; 2020; 13():1625-1635. PubMed ID: 32110058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.
    Guo C; Ma J; Deng G; Qu Y; Yin L; Li Y; Han Y; Cai C; Shen H; Zeng S
    J Cancer; 2017; 8(17):3555-3566. PubMed ID: 29151941
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Cyanidin-3-
    Kurter H; Basbinar Y; Ellidokuz H; Calibasi-Kocal G
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.
    He Y; Xie H; Yu P; Jiang S; Wei L
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1049-1059. PubMed ID: 30302523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway.
    Yin J; Wang L; Wang Y; Shen H; Wang X; Wu L
    Onco Targets Ther; 2019; 12():3893-3903. PubMed ID: 31190888
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
    Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
    World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFI6 Downregulation Reverses Oxaliplatin Resistance of Colorectal Cancer Cells by Activating the ROS-Induced p38MAPK Signaling Pathway.
    Huang C; Zhou T; Ma L; Zhao S
    Biol Pharm Bull; 2023; 46(1):26-34. PubMed ID: 36596524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
    Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin F
    Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
    World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition.
    Zhou Z; Zhang L; Xie B; Wang X; Yang X; Ding N; Zhang J; Liu Q; Tan G; Feng D; Sun LQ
    Cancer Lett; 2015 Jul; 363(2):137-45. PubMed ID: 25896630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition.
    Li Q; Wu J; Wei P; Xu Y; Zhuo C; Wang Y; Li D; Cai S
    Am J Cancer Res; 2015; 5(6):2022-34. PubMed ID: 26269761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forkhead box C2 promotes the invasion ability of human trophoblast cells through Hedgehog (Hh) signaling pathway.
    Zhang Y; Zhang Y
    Cell Biol Int; 2018 Jul; 42(7):859-866. PubMed ID: 29465790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.
    Børretzen A; Gravdal K; Haukaas SA; Beisland C; Akslen LA; Halvorsen OJ
    J Pathol Clin Res; 2019 Oct; 5(4):272-286. PubMed ID: 31464093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
    Xu R; Yin J; Zhang Y; Zhang S
    J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.
    Xu T; Zhou M; Peng L; Kong S; Miao R; Shi Y; Sheng H; Li L
    Int J Clin Exp Pathol; 2014; 7(11):7432-41. PubMed ID: 25550778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression.
    Li JM; Jiang GM; Zhao L; Yang F; Yuan WQ; Wang H; Luo YQ
    Oncol Rep; 2019 Nov; 42(5):1725-1734. PubMed ID: 31436301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R; Fang C; Xu J; Tan H; Li P; Ma L
    Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.